As of 2025-12-28, the Relative Valuation of Avidity Biosciences Inc (RNA) is (89.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.13 USD, the upside of Avidity Biosciences Inc based on Relative Valuation is -224.6%.
The range of the Relative Valuation is (80.13) - (87.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 24.1x | 21.8x |
| Forward P/E multiples | 22.0x - 32.9x | 27.4x |
| Fair Price | (80.13) - (87.86) | (89.85) |
| Upside | -211.1% - -221.8% | -224.6% |
| Date | P/E |
| 2025-12-24 | -19.78 |
| 2025-12-23 | -19.77 |
| 2025-12-22 | -19.79 |
| 2025-12-19 | -19.83 |
| 2025-12-18 | -19.77 |
| 2025-12-17 | -19.70 |
| 2025-12-16 | -19.72 |
| 2025-12-15 | -19.69 |
| 2025-12-12 | -19.69 |
| 2025-12-11 | -19.62 |
| 2025-12-10 | -19.55 |
| 2025-12-09 | -19.54 |
| 2025-12-08 | -19.53 |
| 2025-12-05 | -19.63 |
| 2025-12-04 | -19.61 |
| 2025-12-03 | -19.62 |
| 2025-12-02 | -19.61 |
| 2025-12-01 | -19.55 |
| 2025-11-28 | -19.65 |
| 2025-11-26 | -19.61 |
| 2025-11-25 | -19.61 |
| 2025-11-24 | -19.51 |
| 2025-11-21 | -19.34 |
| 2025-11-20 | -19.36 |
| 2025-11-19 | -19.43 |
| 2025-11-18 | -19.42 |
| 2025-11-17 | -19.37 |
| 2025-11-14 | -19.40 |
| 2025-11-13 | -19.42 |
| 2025-11-12 | -19.41 |
| 2025-11-11 | -19.38 |
| 2025-11-10 | -19.14 |
| 2025-11-07 | -19.14 |
| 2025-11-06 | -19.12 |
| 2025-11-05 | -19.13 |
| 2025-11-04 | -19.14 |
| 2025-11-03 | -19.13 |
| 2025-10-31 | -19.14 |
| 2025-10-30 | -19.10 |
| 2025-10-29 | -19.09 |
| 2025-10-28 | -19.17 |
| 2025-10-27 | -19.18 |
| 2025-10-24 | -13.47 |
| 2025-10-23 | -13.31 |
| 2025-10-22 | -12.84 |
| 2025-10-21 | -13.44 |
| 2025-10-20 | -13.43 |
| 2025-10-17 | -13.13 |
| 2025-10-16 | -13.37 |
| 2025-10-15 | -13.83 |